Page last updated: 2024-11-06

thyroxine and Hyperlipemia

thyroxine has been researched along with Hyperlipemia in 149 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Research Excerpts

ExcerptRelevanceReference
"Subclinical hypothyroidism (SCH) has been associated with increased carotid intima-media thickness (C-IMT) in recent studies, but the effects of levothyroxine (L-T4) therapy on C-IMT in SCH patients are still controversial."8.95Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. ( Chen, B; Shan, Z; Wang, H; Wang, X; Zhang, Y; Zhao, T; Zhou, Y, 2017)
"Bexarotene is an oral retinoid therapy that is effective for the treatment of early and advanced-stage cutaneous T-cell lymphoma (CTCL) in patients who have failed on other therapies."8.83Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion. ( Assaf, C; Bagot, M; Dummer, R; Duvic, M; Gniadecki, R; Knobler, R; Ranki, A; Schwandt, P; Whittaker, S, 2006)
"The familial dysalbuminemic hyperthyroxinemia (FDH) phenotype results from a natural human serum albumin (HSA) mutant with histidine instead of arginine at amino acid position 218."7.69Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. ( Bhagavan, NV; Ha, CE; Jameson, DM; Petersen, CE, 1996)
"Since hyperlipidemia was not improved by pravastatin, atorvastatin or niceritrol, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0."5.33Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism. ( Kiya, Y; Miura, S; Saku, K; Urata, H; Zhang, B, 2006)
"The significance of dyslipidemia in subclinical hypothyroidism (SH) and the effect of thyroid substitution on lipids remain controversial."5.31Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? ( Bairaktari, ET; Bitsis, S; Efstathiadou, Z; Elisaf, MS; Kukuvitis, A; Milionis, HJ; Tsatsoulis, A, 2001)
"To induce hyperlipemia in vitro, IV fat emulsion was diluted in deionized water to produce 0 (water only), 33, 67, or 100% mixtures."5.28Effects of hyperlipemia on radioimmunoassays for progesterone, testosterone, thyroxine, and cortisol in serum and plasma samples from dogs. ( Lamb, SV; Lee, DE; Reimers, TJ, 1991)
"Subclinical hypothyroidism (SCH) has been associated with increased carotid intima-media thickness (C-IMT) in recent studies, but the effects of levothyroxine (L-T4) therapy on C-IMT in SCH patients are still controversial."4.95Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. ( Chen, B; Shan, Z; Wang, H; Wang, X; Zhang, Y; Zhao, T; Zhou, Y, 2017)
"L-thyroxine (LT4) treatment of hypothyroidism, particularly in patients with thyroid- stimulating hormone (TSH) >10mU/L, results in improved lipid profile, as LT4 stimulates low-density lipoprotein cholesterol (LDL-C) degradation and the conversion of cholesterol in bile acids by inducing LDL-receptor and 7 alpha hydroxylase expression, respectively."4.93Thyroid hormones: a potential ally to LDL-cholesterol-lowering agents. ( Brenta, G; Duntas, LH, 2016)
"Bexarotene is an oral retinoid therapy that is effective for the treatment of early and advanced-stage cutaneous T-cell lymphoma (CTCL) in patients who have failed on other therapies."4.83Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion. ( Assaf, C; Bagot, M; Dummer, R; Duvic, M; Gniadecki, R; Knobler, R; Ranki, A; Schwandt, P; Whittaker, S, 2006)
"To determine whether the literature supports an effect of subclinical hypothyroidism on serum lipids and, if so, what are the effects of thyroxine replacement therapy."4.82Effects of subclinical hypothyroidism and its treatment on serum lipids. ( Ineck, BA; Ng, TM, 2003)
"Bexarotene produce as predictable side effects severe mixed hyperlipidemia with marked decrease in HDL-cholesterol levels and central hypothyroidism, being the both reversible and dose-dependent."3.83[Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma]. ( Garcia Morillo, JS; Muñiz Grijalvo, O; Pamies Andreu, E; Rodriguez Suarez, S, 2016)
" Patients with hypothyroidism were identified by means of a computed database, from January 1, 1989, to July 1, 1993, first by levothyroxine sodium medication and second by serum thyrotropin values greater than 5 mU/L."3.69Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. ( Diekman, T; Kastelein, JJ; Lansberg, PJ; Wiersinga, WM, 1995)
"The familial dysalbuminemic hyperthyroxinemia (FDH) phenotype results from a natural human serum albumin (HSA) mutant with histidine instead of arginine at amino acid position 218."3.69Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. ( Bhagavan, NV; Ha, CE; Jameson, DM; Petersen, CE, 1996)
"Concentrations of serum cholesterol, triglyceride, and free glycerol were neasured, and serum lipoprotein electrophoresis was performed in normal dogs and in dogs with hypothyroidism, diabetes mellitus, and acute pancreatitis."3.65Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoproteinemia. ( Donovan, EF; Kociba, GJ; Rogers, WA, 1975)
"Low-T3 syndrome is a strong predictor of death in cardiac patients and might be directly implicated in the poor prognosis of cardiac patients."2.71Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. ( Donato, L; Iervasi, G; L'Abbate, A; Landi, P; Pingitore, A; Raciti, M; Ripoli, A; Scarlattini, M, 2003)
"Halofenate is a new antilipemic drug which is an ester of carboxylic acid."2.64The metabolic spectrum of halofenate. ( Ryan, JR, 1975)
"Bexarotene has been FDA-approved for the treatment of CTCL, but previous studies have been conducted on CD4+ CTL and there have been no reports about its use in CD8+ CTCL."2.44CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature. ( Abbott, L; Farah, R; Gopaluni, S; Hutchison, R; Perzova, R; Poiesz, BJ; Shrimpton, A, 2008)
"The nephrotic syndrome is the only hypoalbuminaemic state frequently associated with hyperlipidaemia."2.35Biochemical anomalies of the nephrotic syndrome. ( Gabriel, R; Lewith, G, 1975)
"Diabetic lipemia, although common in type 2 diabetes, is rare in type 1 diabetes mellitus."1.40Diabetic lipemia presenting as eruptive xanthomas in a child with autoimmune polyglandular syndrome type IIIa. ( Batra, P; Shah, D; Singhal, R, 2014)
"Primary hypothyroidism and type 2 diabetes are both typically associated with the increased level of triglycerides."1.33A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas. ( Chang, SH; Chung, SI; Hahm, JR; Jung, JH; Jung, TS; Kim, DR; Kim, MA; Lee, GW; Park, JR; Park, KJ, 2005)
"Since hyperlipidemia was not improved by pravastatin, atorvastatin or niceritrol, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0."1.33Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism. ( Kiya, Y; Miura, S; Saku, K; Urata, H; Zhang, B, 2006)
"Hyperlipidemia is a secondary disorder associated with many metabolic disorders including hypothyroidism."1.32The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders. ( Abdel-Gayoum, AA; Al-Tonsi, AA; Saad, M, 2004)
"Finally, hemolysis and lipemia significantly interfered with cortisol and fT4 measurements, whereas bilirubinemia did not affect the results."1.32Cortisol and free thyroxine determination by time-resolved fluorometry in canine serum. ( Bernal, LJ; Cerón, JJ; Parra, MD, 2004)
"The significance of dyslipidemia in subclinical hypothyroidism (SH) and the effect of thyroid substitution on lipids remain controversial."1.31Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? ( Bairaktari, ET; Bitsis, S; Efstathiadou, Z; Elisaf, MS; Kukuvitis, A; Milionis, HJ; Tsatsoulis, A, 2001)
"To induce hyperlipemia in vitro, IV fat emulsion was diluted in deionized water to produce 0 (water only), 33, 67, or 100% mixtures."1.28Effects of hyperlipemia on radioimmunoassays for progesterone, testosterone, thyroxine, and cortisol in serum and plasma samples from dogs. ( Lamb, SV; Lee, DE; Reimers, TJ, 1991)
"Contrasting clinical pictures of cretinism, which appeared related to age and previous treatment were found with a spectrum ranging from predominantly myxoedematous in the youngest to predominantly neurological in the 16 year old male."1.28Central cretinism in four successive siblings. ( Das, SC; Egbuta, JO; Isichei, UP, 1990)
"Cholesterol induced hyperlipidemia was controlled by garlic feeding."1.27Hypolipidemic effect of garlic and thyroid function. ( Chakravarty, SK; Chaudhuri, BN; Mongia, SS; Mukherjee, SK, 1984)
"In a patient with type II hyperlipemia, the extravascular recycling pathway is reduced and is not corrected with D-thyroxine therapy."1.26Incorporation of 75Se-selenomethionine into human apoproteins. III. Kinetic behavior of isotopically labeled plasma apoprotein in man. ( Crespin, S; Eaton, RP; Kipnis, DM, 1976)
"Combined hyperlipidemia was common (77%), and lipoprotein phenotyping revealed types IIB hyperlipopro-teinemia in 11, IIA in 5, III in 3 and IV in 3 patients."1.26Hypothyroidism, an important cause of reversible hyperlipidemia. ( Crowther, SM; Mishkel, MA, 1977)
"Hyperlipemia is one of several risk factors for premature ischemic vascular disease."1.26A pathophysiologic approach to managing hyperlipemia. ( Hazzard, WR, 1976)

Research

Studies (149)

TimeframeStudies, this research(%)All Research%
pre-1990107 (71.81)18.7374
1990's17 (11.41)18.2507
2000's17 (11.41)29.6817
2010's8 (5.37)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, T1
Chen, B1
Zhou, Y1
Wang, X1
Zhang, Y1
Wang, H1
Shan, Z1
Domouzoglou, EM1
Fisher, FM1
Astapova, I1
Fox, EC1
Kharitonenkov, A1
Flier, JS1
Hollenberg, AN1
Maratos-Flier, E1
Batra, P1
Singhal, R1
Shah, D1
Rodriguez Suarez, S1
Pamies Andreu, E1
Muñiz Grijalvo, O1
Garcia Morillo, JS1
Hasanato, R1
Brearton, S1
Alshebani, M1
Bailey, L1
Aldugashim, S1
Alothaim, A1
Tamimi, W1
Yang, N1
Zhang, DL1
Hao, JY1
Wang, G1
Duntas, LH1
Brenta, G1
Gopaluni, S1
Perzova, R1
Abbott, L1
Farah, R1
Shrimpton, A1
Hutchison, R1
Poiesz, BJ1
Rosario, M1
Song, SX1
McCullough, LD1
Iervasi, G1
Pingitore, A1
Landi, P1
Raciti, M1
Ripoli, A1
Scarlattini, M1
L'Abbate, A1
Donato, L1
Ineck, BA1
Ng, TM1
SALA, L1
DAVIS, OF1
BECK, C1
BERGAL, M1
SLOAN, N1
LEVINE, AJ1
BERNHEIM, C2
FORSTER, G2
LUETHY, E1
SHIPP, JC1
MUNROE, JF1
SOULAIRAC, A1
CAHN, J1
BARON, J1
SEARCY, RL1
CRAIG, RG1
GIDDINGS, JA1
BERGQUIST, LM1
PRIOR, IA1
CAMPBELL, DG1
FELDMAN, EB1
CARTER, AC1
MUELLER, J1
ALSLEBEN, U1
Jublanc, C1
Bruckert, E4
Giral, P4
Chapman, MJ1
Leenhardt, L1
Carreau, V1
Turpin, G4
HERTZ, R1
SCHRICKER, JA1
TULLNER, WW1
Al-Tonsi, AA1
Abdel-Gayoum, AA1
Saad, M1
Parra, MD1
Bernal, LJ1
Cerón, JJ1
Landén, M1
Baghaei, F1
Rosmond, R1
Holm, G1
Björntorp, P1
Eriksson, E1
Földes, J1
Bános, C1
Winkler, G1
Park, JR1
Jung, TS1
Jung, JH1
Lee, GW1
Kim, MA1
Park, KJ1
Kim, DR1
Chang, SH1
Chung, SI1
Hahm, JR1
Tokinaga, K1
Oeda, T1
Suzuki, Y1
Matsushima, Y1
Assaf, C1
Bagot, M1
Dummer, R1
Duvic, M1
Gniadecki, R1
Knobler, R1
Ranki, A1
Schwandt, P2
Whittaker, S1
Kiya, Y1
Miura, S1
Zhang, B1
Urata, H1
Saku, K1
Asvold, BO1
Vatten, LJ1
Nilsen, TI1
Bjøro, T1
Hollander, CS1
Thompson, RH1
Barrett, PV1
Berlin, NI1
Tamási, G1
Borsy, J1
Patthy, A1
Miettinen, TA1
Carter, JK1
Smith, RE1
Chaudhuri, BN1
Mukherjee, SK1
Mongia, SS1
Chakravarty, SK1
Berdanier, CD1
Ying, C1
Miyada, D1
Gwinup, G1
Simpkins, H1
Laskarzewski, P1
Kelly, KA1
Mellies, MJ1
Morrison, JA1
Khoury, P1
Tillett, S1
Glueck, CJ2
Diekman, T1
Lansberg, PJ1
Kastelein, JJ1
Wiersinga, WM1
Petrasch, SG1
Mlynek-Kersjes, ML1
Haase, R1
Benker, G1
Olbricht, T1
Paar, D1
Reinwein, D1
Shakir, KM1
Kroll, S1
Aprill, BS1
Drake, AJ1
Eisold, JF1
Koshiyama, H1
Koh, T1
Sone, T1
Surks, MI1
Ocampo, E1
Petersen, CE1
Ha, CE1
Jameson, DM1
Bhagavan, NV1
Lang, JE1
Wang, P1
Mariotti, S1
Cabula, R1
Petrini, L1
Caradonna, A1
Mercuro, G1
Cherchi, A1
Lindsay, RS1
Toft, AD1
Chadarevian, R3
Ankri, A1
Beucler, I1
Helfand, M1
Redfern, CC1
Lucena, R1
Moreno, P1
Pérez-Rico, A1
Ginel, PJ1
Tsimihodimos, V1
Bairaktari, E1
Tzallas, C1
Miltiadus, G1
Liberopoulos, E2
Elisaf, M2
Miltiadous, G1
Chu, JW1
Crapo, LM1
Efstathiadou, Z1
Bitsis, S1
Milionis, HJ1
Kukuvitis, A1
Bairaktari, ET1
Elisaf, MS1
Tsatsoulis, A1
Jorde, R1
Ryan, JR1
Miyamoto, M1
Inoue, K1
Kojima, T1
Nagashima, N1
Ban, Y2
Halawa, B1
Mazurek, W1
Schwartzkopff, W3
Russ, E2
Rogers, WA1
Donovan, EF1
Kociba, GJ1
Lewith, G1
Gabriel, R1
Simons, LA1
Myant, NB1
Eaton, RP1
Crespin, S1
Kipnis, DM1
Patsch, JR1
Patsch, W1
Sailer, S3
Braunsteiner, H1
Hempel, RD1
Müller, G2
Burchardt, U1
Ballantyne, FC1
Epenetos, AA1
Caslake, M1
Forsythe, S1
Ballantyne, D1
Kopp, H1
Knüchel, F1
Mertz, DP1
Ciświcka-Sznajderman, M1
Howard, AN1
Mishkel, MA1
Crowther, SM1
Wahlqvist, ML1
Fidge, NH1
Lomas, F1
Hazzard, WR1
Rakow, AD1
Klor, HU1
Kuter, E1
Ditschuneit, HH1
Ditschuneit, H2
Jackson, P1
Lees, S1
Pow, M1
Willing, GW1
Watson, D1
Gless, KH1
Oster, P1
Hüfner, M1
Parsons, WB1
Kubasta, M1
Vaverková, H1
Beaumont, V1
Margolis, S2
Haacke, H1
Kolenda, KD1
Lee, DE1
Lamb, SV1
Reimers, TJ1
Isichei, UP1
Das, SC1
Egbuta, JO1
Kessler, AC1
Rudorff, KH1
Oellerich, M1
Horn, K1
Mattersberger, J1
Hesch, RD1
LaFranchi, S1
Hanna, CE1
Illingworth, DR1
Sato, R1
Kushima, K1
Hara, H1
Nagakura, H1
Kumaoka, S1
Emmrich, R1
Guerre, J1
Fredrickson, DS1
von Löwis of Menar, P1
Klemens, UH1
Manning, PJ1
Corwin, LA1
Middleton, CC1
Levy, RI2
Rifking, BM1
Morganroth, J1
Rifkind, BM1
Vastesaeger, M1
Blaton, V1
Declercq, B1
Vercruysse, J1
Vandamme, D1
Peeters, H1
Mortelmans, J1
Albrink, MJ1
Bybee, DE1
Hamilton, RD1
Edwards, KD2
Schlierf, G1
Michajlik, A1
Sirtori, C1
Fumagalli, R1
Paoletti, R2
Howe, R1
Davis, PJ1
Hsu, TH1
Bianchine, JR1
Morgan, JP1
DePalma, RG1
Insull, W1
Bellon, EM1
Roth, WT1
Robinson, AV1
Felt, V1
Strasek, J1
Bednár, J1
Bommer, J1
Ehrke, V1
Speders, H1
Baum, D1
Guthrie, R1
Brunzell, JD1
Vogel, WC1
Bierman, EL1
Parwaresch, MR1
Mäder, C1
Hill, W1
Wiswedel, K1
Mlotowski, T1
Wermut, W1
Rynkiewicz, H1
Szutowicz, A1
Crepaldi, G1
Fellin, R1
Briani, G1
Huth, K1
Blumenthal, J1
Schmahl, FW1
Yoshitoshi, Y1
Naito, C1
Parker, F1
Short, JM1
Yamazaki, H1
Nanbu, S1
Gomes, MM1
Bernatz, PE1
Kottke, BA1
Juergens, JL1
Titus, JL1
Gillman, J1
Gilbert, C1
Schurr, PE1
Schultz, JR1
Parkinson, TM1
Likoff, W1
LaRosa, JC1
Lewis, M1
Iammarino, RM1
Irsigler, K1
Flegel, U1
Avogaro, P1
Capri, C1
Cazzolato, G1
Pometta, D1
Usardi, MM1
Galli, C1
Strisower, EH3
Adamson, G2
Strisower, B2
Wagner, A1
Maha, GE1
Mazzei, ES1
Mazzei, CM1
Gotelli, C1
Chiche, P1
Chekler, P1
Ribadeau-Dumas, JL1
Derrida, R1
Serio, M1
Zilli, A1
Tinti, P1
Raspa, G1
Steger, H1
Schettler, G1
Baker, BM1
Porte, D2
O'Hara, DD2
Williams, RH2

Reviews

31 reviews available for thyroxine and Hyperlipemia

ArticleYear
Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis.
    BMJ open, 2017, Oct-22, Volume: 7, Issue:10

    Topics: Blood Pressure; Carotid Intima-Media Thickness; Humans; Hyperlipidemias; Hypertension; Hypothyroidis

2017
Thyroid hormones: a potential ally to LDL-cholesterol-lowering agents.
    Hormones (Athens, Greece), 2016, Volume: 15, Issue:4

    Topics: Cholesterol, LDL; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors;

2016
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature.
    American journal of hematology, 2008, Volume: 83, Issue:9

    Topics: Antineoplastic Agents; Azetidines; Bexarotene; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Co

2008
Effects of subclinical hypothyroidism and its treatment on serum lipids.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:5

    Topics: Humans; Hyperlipidemias; Hypothyroidism; Lipids; Thyroxine

2003
[Subclinical hypothyroidism and arteriosclerosis].
    Orvosi hetilap, 2004, Aug-01, Volume: 145, Issue:31

    Topics: Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Humans; Hyperlipidemias; Hypothyroidism; Lipid

2004
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion.
    The British journal of dermatology, 2006, Volume: 155, Issue:2

    Topics: Anticarcinogenic Agents; Bexarotene; Humans; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism;

2006
Effects of hypolipidemic drugs on bile acid metabolism in man.
    Advances in lipid research, 1981, Volume: 18

    Topics: Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fiber; Feces; Hum

1981
[The heart and hypothyroidism].
    Cardiologia (Rome, Italy), 1995, Volume: 40, Issue:12 Suppl 1

    Topics: Arteriosclerosis; Autoimmunity; Cardiovascular System; Echocardiography; Exercise Test; Heart Diseas

1995
Hypothyroidism.
    Lancet (London, England), 1997, Feb-08, Volume: 349, Issue:9049

    Topics: Humans; Hyperlipidemias; Hypothyroidism; Thyrotropin; Thyroxine

1997
Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians.
    Annals of internal medicine, 1998, Jul-15, Volume: 129, Issue:2

    Topics: Adult; Cost of Illness; Female; Humans; Hyperlipidemias; Hyperthyroidism; Hypothyroidism; Mass Scree

1998
The treatment of subclinical hypothyroidism is seldom necessary.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:10

    Topics: Adult; Aged; Arteriosclerosis; Female; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypothy

2001
["Subclinical" thyroid disease].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2002, Apr-10, Volume: 122, Issue:9

    Topics: Cardiovascular Diseases; Diagnosis, Differential; Humans; Hyperlipidemias; Hypothyroidism; Risk Fact

2002
Biochemical anomalies of the nephrotic syndrome.
    Current medical research and opinion, 1975, Volume: 3, Issue:4

    Topics: Animals; Carbohydrate Metabolism; Cholesterol; Fatty Acids, Nonesterified; Humans; Hyperlipidemias;

1975
[Familial hyperlipoproteinemia type III].
    Deutsche medizinische Wochenschrift (1946), 1976, Oct-29, Volume: 101, Issue:44

    Topics: Age Factors; Cholesterol; Chylomicrons; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipo

1976
[Pharmacological treatment of primary hyperlipoproteinemia].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1976, Feb-16, Volume: 31, Issue:7

    Topics: Cholesterol; Clofibrate; Depression, Chemical; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipopr

1976
Hypolipaemic drugs and coronary heart disease.
    Journal of clinical pathology. Supplement (Royal College of Pathologists), 1975, Volume: 9

    Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise

1975
A physician's guide to hyperlipidemia.
    Modern concepts of cardiovascular disease, 1972, Volume: 41, Issue:7

    Topics: Adult; Cholesterol; Chylomicrons; Clofibrate; Diabetes Complications; Diet Therapy; Female; Humans;

1972
Dietary and drug treatment of primary hyperlipoproteinemia.
    Annals of internal medicine, 1972, Volume: 77, Issue:2

    Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy;

1972
Lipid lowering drugs and hyperlipidaemia.
    Drugs, 1973, Volume: 6, Issue:1

    Topics: Biological Transport; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate;

1973
Treatment of hyperlipidemia.
    The New England journal of medicine, 1974, Jun-06, Volume: 290, Issue:23

    Topics: Blood Proteins; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Costs and Cost Analysis

1974
Dietary and drug treatment of hyperlipidemia in diabetes.
    Diabetes, 1974, Volume: 23, Issue:11

    Topics: Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diabetes M

1974
The primary hyperlipoproteinemias.
    The Journal of the Kentucky Medical Association, 1974, Volume: 72, Issue:12

    Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Humans; Hyperc

1974
Antilipaemic drugs and nephrotic hyperlipidaemia.
    Progress in biochemical pharmacology, 1972, Volume: 7

    Topics: Alkenes; Animals; Blood Protein Disorders; Blood Proteins; Butyrates; Clofibrate; Humans; Hyperchole

1972
[Hiperlipidemia as a risk factor in coronary artery disease].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1973, Mar-15, Volume: 26, Issue:6

    Topics: Age Factors; Blood Protein Disorders; Cholesterol; Clofibrate; Coronary Disease; Diet Therapy; Human

1973
Hypolipidemic drugs.
    Advances in experimental medicine and biology, 1973, Volume: 38

    Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; C

1973
Hypolipidaemic agents.
    Advances in drug research, 1974, Volume: 9

    Topics: Androgens; Anticholesteremic Agents; Bile Acids and Salts; Chlorobenzenes; Clofibrate; Estrogens; Gl

1974
[Cause of hyperlipemia in nephrotic syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 1968, Volume: 26, Issue:5

    Topics: Animals; Arteriosclerosis; Cholesterol; Fatty Acids, Nonesterified; Glycogen; Humans; Hyperlipidemia

1968
Xanthomatosis associated with hyperlipoproteinemia.
    The Journal of investigative dermatology, 1970, Volume: 55, Issue:2

    Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Chylomicrons; Clofibrate; D

1970
[Recent advances in biochemistry in clinical pathology].
    Rinsho byori. The Japanese journal of clinical pathology, 1971, Volume: 19, Issue:2

    Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Animals; Arteriosclerosis; Blood Protein Electrophoresis;

1971
[Therapy of hyperlipidemia].
    Das Deutsche Gesundheitswesen, 1971, Oct-21, Volume: 26, Issue:43

    Topics: Alkenes; Animals; Arteriosclerosis; Cholesterol; Clofibrate; Diet Therapy; Fatty Acids; Humans; Hype

1971
Ileal bypass in treatment of hyperlipidemia: rationale and present status.
    Mayo Clinic proceedings, 1970, Volume: 45, Issue:3

    Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Haplorhini;

1970

Trials

9 trials available for thyroxine and Hyperlipemia

ArticleYear
Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease.
    Circulation, 2003, Feb-11, Volume: 107, Issue:5

    Topics: Aged; Female; Follow-Up Studies; Heart Diseases; Humans; Hyperlipidemias; Logistic Models; Male; Mid

2003
Nicotinic acid decreases serum thyroid hormone levels while maintaining a euthyroid state.
    Mayo Clinic proceedings, 1995, Volume: 70, Issue:6

    Topics: Adult; Female; Humans; Hyperlipidemias; Liver; Liver Function Tests; Male; Middle Aged; Niacin; Thyr

1995
Relationship between thyroid hormones and plasma D-dimer levels.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:1

    Topics: Adolescent; Adult; Aged; Arteriosclerosis; Biomarkers; Blood Coagulation; Confounding Factors, Epide

1998
The metabolic spectrum of halofenate.
    International journal of clinical pharmacology and biopharmacy, 1975, Volume: 12, Issue:1-2

    Topics: Blood Glucose; Cholesterol; Clinical Trials as Topic; Clofibrate; Creatine Kinase; Glycolates; Halof

1975
[D-thyroxin in the therapy of type IIa and IIb hyperlipoproteinemias].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Jun-01, Volume: 32, Issue:11

    Topics: Adult; Aged; Cholesterol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins,

1977
[Clinical experience with etiroxate hydrochloride in patients with primary hyperlipoproteinemia].
    Die Medizinische Welt, 1977, Jan-28, Volume: 28, Issue:4

    Topics: Cholesterol; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Male; Placebos; Thyroxine; T

1977
Hypolipaemic drugs and coronary heart disease.
    Journal of clinical pathology. Supplement (Royal College of Pathologists), 1975, Volume: 9

    Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise

1975
[Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1975, May-09, Volume: 117, Issue:19

    Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Female; Heart; Heart Diseases; Humans; Hyperlipi

1975
[Effect of highly purified D-thyroxine ("Dyno") in hyperlipoproteinemias type II a and II b].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1972, Volume: 78

    Topics: Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Placebo

1972

Other Studies

110 other studies available for thyroxine and Hyperlipemia

ArticleYear
Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo.
    Endocrinology, 2014, Volume: 155, Issue:5

    Topics: Adipose Tissue, Brown; Animals; Energy Metabolism; Female; Fibroblast Growth Factors; Gene Expressio

2014
Diabetic lipemia presenting as eruptive xanthomas in a child with autoimmune polyglandular syndrome type IIIa.
    Journal of pediatric endocrinology & metabolism : JPEM, 2014, Volume: 27, Issue:5-6

    Topics: Child; Diabetes Mellitus, Type 1; Female; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypothyroidi

2014
[Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma].
    Medicina clinica, 2016, Feb-05, Volume: 146, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Chol

2016
Effects of serum indices interference on hormonal results from the Abbott Architect i2000 immunoassay analyser.
    British journal of biomedical science, 2015, Volume: 72, Issue:4

    Topics: alpha-Fetoproteins; Carcinoembryonic Antigen; Chorionic Gonadotropin, beta Subunit, Human; Ferritins

2015
Serum levels of thyroid hormones and thyroid stimulating hormone in patients with biliogenic and hyperlipidaemic acute pancreatitis: Difference and value in predicting disease severity.
    The Journal of international medical research, 2016, Volume: 44, Issue:2

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bile Ducts; Biomarkers; Female; Humans; Hyperlipidemi

2016
An unusual case of stroke.
    The neurologist, 2012, Volume: 18, Issue:4

    Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diuretics; Female; Furo

2012
[Thyroxin and total lipemia].
    Archivio per le scienze mediche, 1958, Volume: 106, Issue:6

    Topics: Humans; Hyperlipidemias; Lipids; Thyroxine

1958
Some observations on the relationships between atherosclerosis, hyperlipemia, and D-thyroxine.
    American heart journal, 1962, Volume: 64

    Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Dextrothyroxine; Estrogens; Humans; Hyperlipidemias;

1962
[Treatment of hypercholesteremia, hyperlipemia and tuberous xanthomatosis with D-thyroxin].
    Schweizerische medizinische Wochenschrift, 1963, Feb-09, Volume: 93

    Topics: Humans; Hypercholesterolemia; Hyperlipidemias; Thyroxine; Xanthomatosis

1963
Effects of sulfonylurea compounds on hyperlipemia and hypercholesteremia in patients with minimal impairment of glucose tolerance.
    Diabetes, 1962, Volume: 11(Suppl)

    Topics: Carbohydrate Metabolism; Diabetes Mellitus; Glucose; Humans; Hypercholesterolemia; Hyperlipidemias;

1962
[Protective action of D-thyroxin on disorders of ocular vascularization induced in the rabbit by an experimental hypercholesterolemic hyperlipemia].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1963, Jul-10, Volume: 157

    Topics: Animals; Eye; Hypercholesterolemia; Hyperlipidemias; Neovascularization, Pathologic; Rabbits; Retina

1963
Treatment of hyperlipemic diabetic patients. Effects of dextro-thyroxine therapy.
    California medicine, 1963, Volume: 99

    Topics: Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypoglycemi

1963
THE EFFECT OF ATROMID, AN ORALLY ACTIVE ANDROSTERONE ON SERUM LIPIDS IN NORMAL, HYPERCHOLESTEROLAEMIC AND HYPERLIPAEMIC SUBJECTS.
    The New Zealand medical journal, 1963, Volume: 62

    Topics: Androsterone; Aspartate Aminotransferases; Cholesterol; Clofibrate; Glycerides; Humans; Hypercholest

1963
REDUCTION OF SERUM TRIGLYCERIDES IN PATIENTS TREATED WITH SODIUM D-THYROXINE.
    Metabolism: clinical and experimental, 1963, Volume: 12

    Topics: Blood Chemical Analysis; Child; Dextrothyroxine; Glycerides; Hypercholesterolemia; Hyperlipidemias;

1963
[ON THE CLINICAL ASPECTS AND THERAPY OF HYPERLIPEMIA].
    Schweizerische medizinische Wochenschrift, 1964, Jun-20, Volume: 94

    Topics: Arteriosclerosis; Cholesterol; Diabetes Mellitus; Diagnosis, Differential; Dietary Fats; Fatty Acids

1964
Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP.
    Atherosclerosis, 2004, Volume: 172, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Humans; Hyperlipidemias; Middle Aged; Radio

2004
Dietary and dosage factors affecting thyroxine inhibition of estrogen-induced lipemia in the chick.
    Endocrinology, 1951, Volume: 49, Issue:2

    Topics: Animals; Chickens; Diet; Estrogens; Humans; Hyperlipidemias; Lipids; Thyroxine

1951
The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders.
    Experimental and molecular pathology, 2004, Volume: 76, Issue:2

    Topics: Cholesterol; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hyperlipidemias; Middle Aged; Phosph

2004
Cortisol and free thyroxine determination by time-resolved fluorometry in canine serum.
    Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 2004, Volume: 68, Issue:2

    Topics: Animals; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Fluorometry; Hemolysis; Huma

2004
Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety.
    Psychoneuroendocrinology, 2004, Volume: 29, Issue:8

    Topics: Adult; Anxiety Disorders; Body Constitution; Body Mass Index; Cohort Studies; Comorbidity; Female; H

2004
A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas.
    Journal of Korean medical science, 2005, Volume: 20, Issue:3

    Topics: Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fenofibrate; Humans; Hyperlipidemias; Hy

2005
HMG-CoA reductase inhibitors (statins) might cause high elevations of creatine phosphokinase (CK) in patients with unnoticed hypothyroidism.
    Endocrine journal, 2006, Volume: 53, Issue:3

    Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholesterol, HDL; Contraindications; Creati

2006
Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism.
    Endocrine journal, 2006, Volume: 53, Issue:6

    Topics: Electrophoresis, Capillary; Female; Humans; Hyperlipidemias; Hypothyroidism; Lipids; Lipoproteins; M

2006
The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study.
    European journal of endocrinology, 2007, Volume: 156, Issue:2

    Topics: Adult; Age Distribution; Aged; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studi

2007
Repair of the anemia and hyperlipidemia of the hypothyroid dog.
    Endocrinology, 1967, Volume: 81, Issue:5

    Topics: Anemia; Animals; Blood Proteins; Blood Volume; Body Weight; Calorimetry; Dinitrophenols; Dogs; Eryth

1967
Effects of 3-carboxyl-5-methylpyrazole (CMP) on serum and liver lipids in rats.
    Medicina et pharmacologia experimentalis. International journal of experimental medicine, 1967, Volume: 16, Issue:6

    Topics: Animals; Fatty Acids, Nonesterified; Heparin; Hyperlipidemias; Liver; Male; Nicotinic Acids; Pyrazol

1967
Specificity of avian leukosis virus-induced hyperlipidemia.
    Journal of virology, 1984, Volume: 50, Issue:2

    Topics: Animals; Avian Leukosis Virus; Body Weight; Chick Embryo; Chickens; Hyperlipidemias; Insulin; Liver;

1984
Hypolipidemic effect of garlic and thyroid function.
    Biomedica biochimica acta, 1984, Volume: 43, Issue:7

    Topics: Animals; Cholesterol, Dietary; Dietary Fats; Female; Garlic; Hyperlipidemias; Iodides; Lipids; Male;

1984
Effects of thyroid hormone on the gluconeogenic capacity of lipemic BHE rats.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1983, Volume: 172, Issue:2

    Topics: Animals; Gluconeogenesis; Hyperlipidemias; In Vitro Techniques; Kinetics; Liver; Male; Rats; Rats, I

1983
Effect of hyperlipidemia on homogeneous enzyme immunoassay for thyroxine.
    Clinical chemistry, 1981, Volume: 27, Issue:2

    Topics: Glucosephosphate Dehydrogenase; Humans; Hyperlipidemias; Immunoenzyme Techniques; Lipids; Malate Deh

1981
Clinical chemistry determinations for a biracial cohort of 1,605 normal and hyperlipidemic schoolchildren aged 6 to 17.
    American journal of clinical pathology, 1980, Volume: 74, Issue:4

    Topics: Adolescent; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Child; Crea

1980
Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia.
    Archives of internal medicine, 1995, Jul-24, Volume: 155, Issue:14

    Topics: Aged; Cholesterol, LDL; Female; Follow-Up Studies; Humans; Hyperlipidemias; Hypothyroidism; Lipids;

1995
Basophilic leukocytes in hypothyroidism.
    The Clinical investigator, 1993, Volume: 71, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Basophils; Cholesterol; Humans; Hyperlipidemias; Hypothyroidism; Leu

1993
Therapeutic dilemma with thyroxine replacement in hypothyroidism.
    Archives of internal medicine, 1994, Sep-12, Volume: 154, Issue:17

    Topics: Bone Density; Cholesterol; Humans; Hyperlipidemias; Hypothyroidism; Thyroxine

1994
Subclinical thyroid disease.
    The American journal of medicine, 1996, Volume: 100, Issue:2

    Topics: Heart; Humans; Hyperlipidemias; Hyperthyroidism; Hypothyroidism; Thyroid Function Tests; Thyrotropin

1996
Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia.
    The Journal of biological chemistry, 1996, Aug-09, Volume: 271, Issue:32

    Topics: Binding Sites; Humans; Hyperlipidemias; Hyperthyroxinemia; Recombinant Proteins; Serum Albumin; Thyr

1996
Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism.
    Clinica chimica acta; international journal of clinical chemistry, 1996, Oct-15, Volume: 254, Issue:1

    Topics: Aged; Anticholesteremic Agents; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gemfibrozil; Huma

1996
Effects of haemolysis, lipaemia and bilirubinaemia on an enzyme-linked immunosorbent assay for cortisol and free thyroxine in serum samples from dogs.
    Veterinary journal (London, England : 1997), 1998, Volume: 156, Issue:2

    Topics: Animals; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Hemolysis; Hydrocortisone; Hyperbili

1998
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic.
    Thyroid : official journal of the American Thyroid Association, 1999, Volume: 9, Issue:4

    Topics: Dose-Response Relationship, Drug; Fasting; Female; Humans; Hyperlipidemias; Hypothyroidism; Incidenc

1999
Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients.
    Journal of cardiovascular risk, 1999, Volume: 6, Issue:5

    Topics: Adult; Aged; Arteriosclerosis; Carotid Stenosis; Humans; Hyperlipidemias; Male; Middle Aged; Risk Fa

1999
Relationship between thyroid hormones and fibrinogen levels.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10, Issue:8

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Midd

1999
Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism.
    Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:2

    Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fibric Acids; Humans; Hyperlipidemias; Hyperthyr

2001
Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
    European journal of endocrinology, 2001, Volume: 145, Issue:6

    Topics: Adult; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hyperlipi

2001
[Effects of halofenate on thyroxine-binding globulin (TBG) and thyroid function tests using TBG].
    Horumon to rinsho. Clinical endocrinology, 1976, Volume: 24, Issue:3

    Topics: Adult; Aged; Alpha-Globulins; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle

1976
[Serum levels of thyrotropin triiodothyronine, thyroxine and thyroxine-binding proteins in patients with coronary disease and hyperlipoproteinemia of the IIA and IIB types].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1979, May-15, Volume: 32, Issue:10

    Topics: Coronary Disease; Humans; Hyperlipidemias; Middle Aged; Thyrotropin; Thyroxine; Thyroxine-Binding Pr

1979
[Long-term treatment of hyperlipoproteinaemia, types IIa and IIb, with etiroxate (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1975, Apr-11, Volume: 100, Issue:15

    Topics: Adult; Aged; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipoprotein

1975
Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoproteinemia.
    Journal of the American Veterinary Medical Association, 1975, Jun-01, Volume: 166, Issue:11

    Topics: Animals; Cholesterol; Diabetes Complications; Diabetes Mellitus; Dog Diseases; Dogs; Female; Glycero

1975
Cholesterol metabolism in hypertriglyceridaemia and the effects of treatment.
    Clinica chimica acta; international journal of clinical chemistry, 1975, Nov-15, Volume: 65, Issue:1

    Topics: Adult; Alcohol Drinking; Bile Acids and Salts; Cholesterol; Chylomicrons; Diabetes Complications; Di

1975
Incorporation of 75Se-selenomethionine into human apoproteins. III. Kinetic behavior of isotopically labeled plasma apoprotein in man.
    Diabetes, 1976, Volume: 25, Issue:8

    Topics: Adult; Amino Acids; Apoproteins; Heparin; Humans; Hyperlipidemias; Kinetics; Lipoproteins, LDL; Lipo

1976
The composition of low-density lipoprotein and very-low-density lipoprotein subfractions in primary hypothyroidism and the effect of hormone-replacement therapy.
    Clinical science (London, England : 1979), 1979, Volume: 57, Issue:1

    Topics: Aged; Cholesterol; Female; Humans; Hyperlipidemias; Hypothyroidism; Lipoproteins, LDL; Lipoproteins,

1979
[Therapy of disorders of the lipid metabolism which carry the risk of arteriosclerosis].
    MMW, Munchener medizinische Wochenschrift, 1978, May-26, Volume: 120, Issue:21

    Topics: Adult; Body Weight; Drug Evaluation; Female; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Thy

1978
[Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
    Fortschritte der Medizin, 1979, Apr-19, Volume: 97, Issue:15

    Topics: Cholestyramine Resin; Clofibrate; Colestipol; Germany, West; Humans; Hyperlipidemias; Hypolipidemic

1979
Hypothyroidism, an important cause of reversible hyperlipidemia.
    Clinica chimica acta; international journal of clinical chemistry, 1977, Jan-17, Volume: 74, Issue:2

    Topics: Adolescent; Adult; Aged; Cholesterol; Female; Humans; Hyperlipidemias; Hypothyroidism; Lipids; Male;

1977
Lipoprotein composition in hypothyroidism.
    Clinica chimica acta; international journal of clinical chemistry, 1977, Jun-15, Volume: 77, Issue:3

    Topics: Adolescent; Adult; Aged; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypothy

1977
[Hyperlipidemias. Diet and drug therapy].
    ZFA. Zeitschrift fur Allgemeinmedizin, 1977, Oct-31, Volume: 53, Issue:30

    Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine

1977
A pathophysiologic approach to managing hyperlipemia.
    American family physician, 1976, Volume: 14, Issue:2

    Topics: Adult; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Lipid Me

1976
Treatment of type II hyperlipoproteinemia with d-thyroxine.
    Atherosclerosis, 1976, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Cholesterol; Cr

1976
Radioimmunoassay kits for thyroid hormones.
    Journal of clinical pathology, 1976, Volume: 29, Issue:10

    Topics: Blood Proteins; Costs and Cost Analysis; Female; Humans; Hyperlipidemias; Hypothyroidism; Pregnancy;

1976
[TSH-secretion, thyroxine- and triiodothyronine concentrations under D-thyroxine administration].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1976, Volume: 82 Pt 2

    Topics: Humans; Hyperlipidemias; Hypothyroidism; Thyrotropin; Thyroxine; Triiodothyronine

1976
Hyperlipidemia: to treat or not to treat.
    Arizona medicine, 1975, Volume: 32, Issue:4

    Topics: Cerebrovascular Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyper

1975
[Hyperlipoproteinemias in internal medicine and therapeutic possibilities].
    Casopis lekaru ceskych, 1975, Mar-14, Volume: 114, Issue:10-11

    Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine

1975
[Treatment of hyperlipemia. III. Practical modalities].
    La Nouvelle presse medicale, 1975, May-03, Volume: 4, Issue:18

    Topics: Cholestyramine Resin; Clofibrate; Estrogens; Heparin; Humans; Hyperlipidemias; Nicotinic Acids; Thyr

1975
The hyperlipoproteinemias in adolescence.
    The Medical clinics of North America, 1975, Volume: 59, Issue:6

    Topics: Adolescent; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Dietary Carbohydrates; Dietary F

1975
[Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Medizinische Klinik, 1976, Mar-19, Volume: 71, Issue:12

    Topics: Cholestyramine Resin; Clofibrate; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipidem

1976
Effects of hyperlipemia on radioimmunoassays for progesterone, testosterone, thyroxine, and cortisol in serum and plasma samples from dogs.
    American journal of veterinary research, 1991, Volume: 52, Issue:9

    Topics: Animals; Dog Diseases; Dogs; Fat Emulsions, Intravenous; Female; Gonadal Steroid Hormones; Hydrocort

1991
Central cretinism in four successive siblings.
    Postgraduate medical journal, 1990, Volume: 66, Issue:779

    Topics: Adolescent; Child; Congenital Hypothyroidism; Female; Humans; Hyperlipidemias; Male; Thyrotropin; Th

1990
[Methods and clinical evaluation of a new enzyme immunologic method for determination of thyroxin binding globulin (TBG) and T4/TBG quotient: a multicenter study].
    Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie, 1985, Volume: 23, Issue:3

    Topics: Anticoagulants; Chromatography, Gel; Chromatography, Ion Exchange; Hemolysis; Humans; Hyperbilirubin

1985
Effect of growth hormone replacement on development of hypothyroidism and hyperlipidemia.
    The Journal of pediatrics, 1985, Volume: 106, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Cholesterol; Creatine Kinase; Female; Growth; Growth Hormone; H

1985
[Effect of hyperlipidemia on the free thyroxine value by radioimmunoassay].
    Kaku igaku. The Japanese journal of nuclear medicine, 1985, Volume: 22, Issue:9

    Topics: Adult; Aged; Aging; Female; Humans; Hyperlipidemias; Male; Middle Aged; Radioimmunoassay; Reagent Ki

1985
Long-term administration of 3,5-diodo-4(3'-iodo4'-acetoxyphenoxy) benzoic acid (acetiromate) in hyperlipidemic patients.
    Endocrinologia japonica, 1974, Volume: 21, Issue:4

    Topics: Aged; Cholesterol; Drug Evaluation; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Iodobenzo

1974
[Therapy of arteriosclerosis].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1968, Jan-15, Volume: 23, Issue:2

    Topics: Anticholesteremic Agents; Anticoagulants; Arteriosclerosis; Cholesterol; Choline; Diabetes Complicat

1968
[Hyperlipemias].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1965, Oct-26, Volume: 41, Issue:44

    Topics: Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Sterols; Thyroxine

1965
[Therapy of hyperlipoproteinemias type II a and II b using dextro-thyroxine or D,L-alpha-methyl-thyroxine-ethylester].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1972, Volume: 78

    Topics: Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Thyroid

1972
Familial hyperlipoproteinemia and thyroid dysfunction of beagles.
    Experimental and molecular pathology, 1973, Volume: 19, Issue:3

    Topics: Aging; Animals; Cholesterol; Dogs; Electrophoresis; Glucose Tolerance Test; Glycerides; Humans; Hype

1973
Comparative treatment of hyperlipoproteinaemias in chimpanzees.
    Acta zoologica et pathologica Antverpiensia, 1974, Volume: 58, Issue:0

    Topics: Animals; Cholesterol; Clofibrate; Diet, Atherogenic; Fatty Acids; Female; Hyperlipidemias; Lipoprote

1974
The influence of drugs affecting lipids on atherosclerosis.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1974, Volume: Suppl 4

    Topics: Adult; Arteriosclerosis; Blood Protein Disorders; Clofibrate; Coronary Disease; Diabetes Complicatio

1974
[What is assured in the treatment of hyperlipemia?].
    Der Internist, 1972, Volume: 13, Issue:12

    Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine;

1972
Effects of a new hypolipidemic agents, MK-185, on serum thyroxine-binding globulin (TBG) and dialyzable fraction thyroxine.
    The Journal of clinical endocrinology and metabolism, 1972, Volume: 34, Issue:1

    Topics: Animals; Binding Sites; Blood Protein Electrophoresis; Carbon Isotopes; Cattle; Dialysis; Glycolates

1972
Animal models for the study of progression and regression of atherosclerosis.
    Surgery, 1972, Volume: 72, Issue:2

    Topics: Animals; Aorta; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Coronary

1972
[Index of "unbound" thyroxine in patients with hypercholesterolemia or hypertriglyceridemia treated with clofibrate].
    Casopis lekaru ceskych, 1972, Sep-29, Volume: 111, Issue:40

    Topics: Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Thyroxine; Thy

1972
[Preliminary results of hyperlipemia therapy using a new D-thyroxine preparation].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1972, Volume: 78

    Topics: Adult; Aged; Cholesterol; Female; Humans; Hyperlipidemias; Male; Methods; Middle Aged; Thyroxine

1972
Triglyceride abnormality in infantile hypothyroidism.
    American journal of diseases of children (1960), 1973, Volume: 125, Issue:4

    Topics: Cholesterol; Chylomicrons; Congenital Hypothyroidism; Humans; Hyperlipidemias; Hypothyroidism; Infan

1973
[Experimental induction of atherosclerosis in rabbits by a combined method].
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1973, Jun-19, Volume: 160, Issue:4

    Topics: Animals; Aorta; Arteriosclerosis; Calcinosis; Catecholamines; Cholesterol; Diet, Atherogenic; Hyperl

1973
[Familial hyperlipoproteinemia and its treatment].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1973, Jun-04, Volume: 28, Issue:23

    Topics: Aged; Female; Humans; Hyperlipidemias; Male; Middle Aged; Pedigree; Thyroxine

1973
Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
    Advances in experimental medicine and biology, 1973, Volume: 38

    Topics: Adolescent; Adult; Alcohol Drinking; Body Weight; Child; Cholesterol, Dietary; Cholestyramine Resin;

1973
[Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
    Medizinische Klinik, 1973, Aug-24, Volume: 68, Issue:34

    Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Lipoproteins;

1973
[Hyperlipoproteinemias: significance--diagnosis--therapy].
    Der Internist, 1971, Volume: 12, Issue:11

    Topics: Adolescent; Adult; Blood Protein Disorders; Cardiovascular Diseases; Child; Child, Preschool; Choles

1971
Some aspects of the endocrine control of the serum lipids, blood ketones and blood sugar in fed and fasted baboons, and of the mechanism of fuel control in fasting, with special reference to diabetes and lipaemia.
    Experimental medicine and surgery, 1970, Volume: 28, Issue:1

    Topics: Adrenalectomy; Animals; Blood Glucose; Carbohydrate Metabolism; Castration; Cortisone; Diabetes Mell

1970
Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.
    Lipids, 1972, Volume: 7, Issue:1

    Topics: Animals; Carboxylic Acids; Cholesterol; Clofibrate; Disease Models, Animal; Fasting; Hyperlipidemias

1972
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
    Geriatrics, 1972, Volume: 27, Issue:5

    Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Die

1972
Hyperlipoproteinemia. 3. Drug therapy.
    Postgraduate medicine, 1972, Volume: 52, Issue:2

    Topics: Age Factors; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; Ethers, Cyclic; Humans; H

1972
Lipemia in rodent iron-deficiency anemia.
    The Journal of laboratory and clinical medicine, 1971, Volume: 78, Issue:4

    Topics: Anemia, Hypochromic; Animals; Blood Transfusion; Cholesterol; Electrophoresis; Heparin; Hyperlipidem

1971
[Antilipidemic agents].
    Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1971, Volume: 5, Issue:3

    Topics: Adult; Alcohols; Anticholesteremic Agents; Biguanides; Blood Protein Disorders; Body Weight; Cholest

1971
[Therapy of hyperlipidemias].
    Wiener klinische Wochenschrift, 1971, Oct-01, Volume: 83, Issue:39

    Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Estrogens; Glycine max; Heparin; Humans; Hyperlipidem

1971
[New aspects of the therapy of arteriosclerosis].
    Recenti progressi in medicina, 1971, Volume: 51, Issue:5

    Topics: Arteriosclerosis; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Lipoprote

1971
[Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners].
    Therapeutische Umschau. Revue therapeutique, 1970, Volume: 27, Issue:3

    Topics: Cholestyramine Resin; Clofibrate; Estrogens; Family Practice; Humans; Hypercholesterolemia; Hyperlip

1970
Studies on the pharmacological control of hyperlipemia in experimental nephrotic syndrome.
    Biochemical pharmacology, 1970, Volume: 19, Issue:10

    Topics: Animals; Butyrates; Chemical and Drug Induced Liver Injury; Cholesterol; Cholestyramine Resin; Disea

1970
Treatment of hyperlipidemic states.
    The Medical clinics of North America, 1970, Volume: 54, Issue:6

    Topics: Adult; Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Coronary Disease; Dextrothyroxine;

1970
[Treatment of hyperlipemias].
    Deutsche medizinische Wochenschrift (1946), 1971, Aug-27, Volume: 96, Issue:35

    Topics: Cholesterol; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohydrates; Dietary Fats;

1971
Diet and drug therapy for hyperlipoproteinemia.
    Medical times, 1971, Volume: 99, Issue:8

    Topics: Anticholesteremic Agents; Body Weight; Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbo

1971
[Effect of sodium d-thyroxine on the hiperlipedemia, hypercholesteremia, triglycerides and serum lipoproteins in patients with arteriosclerosis].
    Prensa medica argentina, 1967, Mar-31, Volume: 54, Issue:5

    Topics: Arteriosclerosis; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Thyroxine; Triglyceri

1967
[Antilipemics and atherosclerosis].
    Coeur et medecine interne, 1967, Volume: 6, Issue:2

    Topics: Adult; Aged; Arteriosclerosis; Arteritis; Cerebrovascular Disorders; Cholesterol; Coronary Disease;

1967
[Therapeutic use of a new non-salified D-thyroxine (D-thyroxine acid)].
    Gerontologia clinica, 1968, Volume: 10, Issue:1

    Topics: Adult; Aged; Anticholesteremic Agents; Female; Humans; Hyperlipidemias; Hypothyroidism; Iodine Radio

1968
Treatment of hyperlipidemias.
    The American journal of medicine, 1968, Volume: 45, Issue:4

    Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Butyrates; Diet Therapy; Dietary Carbohydrates; D

1968
[Studies on the effect of d-thyroxine in patients with increased serum lipid level].
    Wiener klinische Wochenschrift, 1968, Nov-22, Volume: 80, Issue:47

    Topics: Adult; Aged; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension, Malig

1968
[Differentiation and drug therapy of lipemias].
    La Clinica terapeutica, 1968, Jun-30, Volume: 44, Issue:6

    Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Platelet Disorders; Carbohydrate Metabolism; Diagn

1968
Control of coronary heart disease--treatment of hyperlipidemia.
    The Johns Hopkins medical journal, 1969, Volume: 124, Issue:4

    Topics: Butyrates; Cholesterol; Coronary Disease; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Humans;

1969
The relation between postheparin lipolytic activity and plasma triglyceride in myxedema.
    Metabolism: clinical and experimental, 1966, Volume: 15, Issue:2

    Topics: Enzymes; Glycerides; Heparin; Humans; Hyperlipidemias; In Vitro Techniques; Lipids; Lipoprotein Lipa

1966
The effect of diet and thyroxin on plasma lipids in myxedema.
    Metabolism: clinical and experimental, 1966, Volume: 15, Issue:2

    Topics: Adult; Cholesterol; Diet; Glycerides; Humans; Hyperlipidemias; Lipids; Lipoproteins; Middle Aged; My

1966
The combined use of CPIB and thyroxine in treatment of hyperlipoproteinemias.
    Circulation, 1966, Volume: 33, Issue:2

    Topics: Adult; Blood Protein Disorders; Butyrates; Dietary Carbohydrates; Drug Synergism; Female; Humans; Hy

1966